Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Trial of High Dose Versus Standard Dose Stereotactic Radiotherapy for Pain Control in Patients With Bone Metastases

NCT04063254 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04063254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04063254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Trial of High Dose Versus Standard Dose Stereotactic Radiotherapy for Pain Control in Patients With Bone Metastases
Lead sponsor
National Taiwan University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 30, 2019
Completion date
August 30, 2021
Enrollment
302 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, radiotherapy side effect